rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples.

rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples.

Item
http://www.wikidata.org/entity/Q44220321
The role of rHuEpo in low-risk myelodysplastic syndrome patients.Durable erythroid response after discontinuation of epoetin-alpha: an unexpected outcome in a patient with myelodysplastic syndrome.Clonal architecture of del(5q) myelodysplastic syndromes: aberrant CD5 or CD7 expression within the myeloid progenitor compartment defines a subset with high clonal burdenSoluble urokinase-type plasminogen activator receptor (suPAR) as an independent factor predicting worse prognosis and extra-bone marrow involvement in multiple myeloma patients.Efficacy of a single, weekly dose of recombinant erythropoietin in myelodysplastic syndromes.Darbepoetin alpha for the treatment of anaemia in low-intermediate risk myelodysplastic syndromes.Sustained resolution of anemia without any treatment after excessive therapeutic response to human recombinant erythropoietin in three patients with myelodysplastic syndromes.Sustained remission in a patient with myelodysplastic syndrome and a complex karyotype after erythropoiesis-stimulating therapy followed by colonic T-cell lymphoblastic lymphoma.
P2860

rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors' response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow samples.

Item
http://www.wikidata.org/entity/Q44220321
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
rHuEpo administration in patie ...... a-stained bone marrow samples.
@en
rHuEpo administration in patie ...... a-stained bone marrow samples.
@nl
type
label
rHuEpo administration in patie ...... a-stained bone marrow samples.
@en
rHuEpo administration in patie ...... a-stained bone marrow samples.
@nl
prefLabel
rHuEpo administration in patie ...... a-stained bone marrow samples.
@en
rHuEpo administration in patie ...... a-stained bone marrow samples.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
rHuEpo administration in patie ...... sa-stained bone marrow samples
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2141.2002.03867.X
P407
P433
P478
P50
P577
P5875
P698